Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ketorolac for pain reduction during panretinal photocoagulation
IRCT20250826067007N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in proliferative diabetic retinopathy (PDR) comparing Ketorolac eye with Placebo eye (2 arms). Primary endpoint: Pain intensity immediately after panretinal photocoagulation. Started Aug 2025; status: completed.
02
Drugs
ketorolac
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on IRCT20250826067007N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250826067007N1.